Testing a new medication for fatty liver disease in people with diabetes

This trial is testing whether bempedoic acid, a medication recently approved for cholesterol management, can help reduce fat buildup in the liver. Researchers want to see if this treatment works better than standard care alone for people who have both type 2 diabetes and fatty liver disease. The study will measure how much fat is in your liver before and after 24 weeks of treatment.

Fatty liver disease is very common in people with type 2 diabetes and can slowly damage the liver if left untreated. While this medication has shown promise in animal studies, doctors need to test it in real patients to see if it actually reduces liver fat and helps prevent serious complications.